Old Web
English
Sign In
Acemap
>
authorDetail
>
Fumihiko Sato
Fumihiko Sato
Taisho Pharmaceutical Co.
Erythropoietin
Secretion
Endocrinology
Kidney disease
Diabetes mellitus
2
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Novel Compound Induces Erythropoietin Secretion through Liver Effects in Chronic Kidney Disease Patients and Healthy Volunteers
2018
American Journal of Nephrology
Aya Shinfuku
Toshiharu Shimazaki
Masanori Fujiwara
Fumihiko Sato
Hirotaka Watase
Takumi Numazaki
Yasunori Kawakita
Masaru Mutoh
Hironori Yamasaki
Noriko Takayama
Sota Kato
Tomohiro Sugimoto
Jinsei Maruyama
Show All
Source
Cite
Save
Citations (5)
SP331TP0463518, A NOVEL ORAL INHIBITOR OF HYPOXIA INDUCIBLE FACTOR PROLYL HYDROXYLASE (HIF-PH) INDUCES ERYTHROPOIETIN SECRETION DOMINANTLY DERIVED FROM LIVER IN NON-DIALYSIS AND HEMODIALYSIS PATIENTS WITH CHRONIC KIDNEY DISEASE
2018
Nephrology Dialysis Transplantation
Shota Tokuyama
Masanori Fujiwara
Fumihiko Sato
Toshiharu Shimazaki
Hirotaka Watase
Aya Shinfuku
Takumi Numazaki
Yasunori Kawakita
Kunika Kikumori
Noriko Takayama
Sota Kato
Tomohiro Sugimoto
Jinsei Maruyama
Show All
Source
Cite
Save
Citations (0)
1